Nano Vision Aims to Disrupt Healthcare

Backed by Softbank’s Arm semiconductor company, Nano Vision is making its way to Switzerland, the CEO, Steve Papermaster, tells CNNMoney Switzerland. Based in the U.S., the molecular data start-up is here for three reasons, he says: Switzerland is a leader in pharma and biotech; it has strong finance and banking industry; and it’s already a power in crypto and blockchain technology, which is emerging on the global scene. With Nanovision, Papermaster hopes to help cure major diseases, such as cancer and superbugs.